Buscar resultados de ensayos clínicos

Patrocinado por

Polycystic Kidney Diseases - 18 Studies Found

Estado Estudiar
Completed Nombre del estudio: Sirolimus (Rapamune®) for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condición: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Fecha: 2006-06-22
Intervenciones:
  • Drug: Sirolimus Standard plus

Completed Nombre del estudio: The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients
Condición: Autosomal Dominant Polycystic Kidney Disease
Fecha: 2014-04-28
Intervenciones:
  • Drug: Everolimus Change from a
Completed Nombre del estudio: Water as Therapy in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condición: Autosomal Dominant Polycystic Kidney Disease
Fecha: 2008-09-24
Intervenciones: Other: Water prescription Water prescription in 12 to 16 equally divided doses
Terminated Nombre del estudio: Sirolimus In Autosomal Dominant Polycystic Kidney Disease And Severe Renal Insufficiency
Condición: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Fecha: 2010-10-12
Intervenciones:
  • Drug: Sirolimus Patients will

Completed Nombre del estudio: A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Study 156-04-001]
Condición: Autosomal Dominant Polycystic Kidney Disease
Fecha: 2009-02-09
Intervenciones: Drug: OPC-41061 orally administered at 15 mg twice daily (morning and evening) for a maximum of 3 years.
Completed Nombre del estudio: A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) (2) [Extension of Study 156-05-002]
Condición: Autosomal Dominant Polycystic Kidney Disease
Fecha: 2009-11-27
Intervenciones: Drug: OPC-41061 Repeated oral administration at doses of 15 mg twice daily (morning and evening)
Terminated Nombre del estudio: Randomized Clinical Trial of Triptolide Woldifii for Autosomal Dominant Polycystic Kidney Disease
Condición: Polycystic Kidney
Fecha: 2008-11-25
Intervenciones:
  • Drug: tripterygium wilfordii T
Completed Nombre del estudio: Triptolide-Containing Formulation as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condición: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Fecha: 2014-04-14
Intervenciones:
  • Drug: Triptolide-Containing Formulation

<<< Previous